Adagene (NASDAQ:ADAG) Receives Buy Rating from HC Wainwright
HC Wainwright reissued their buy rating on shares of Adagene (NASDAQ:ADAG – Get Rating) in a research report released on Wednesday morning, Benzinga reports. The firm currently has a $5.00 target price on the stock. HC Wainwright also issued estimates for Adagene’s FY2023 earnings at ($1.49) EPS, FY2024 earnings at ($1.36) EPS, FY2026 earnings at […]